These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34559983)

  • 1. US FDA delays decision on Juul and other leading e-cigarette brands.
    Furlow B
    Lancet Respir Med; 2021 Dec; 9(12):e115. PubMed ID: 34559983
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of JUUL E-cigarettes Among Youth in the United States.
    Hammond D; Wackowski OA; Reid JL; O'Connor RJ
    Nicotine Tob Res; 2020 Apr; 22(5):827-832. PubMed ID: 30371838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaping: US FDA has issued more than 1200 warning letters over unauthorised tobacco products.
    Mahase E
    BMJ; 2024 Jun; 385():q1267. PubMed ID: 38849139
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA orders Juul to remove all its e-cigarettes from US market.
    Wise J
    BMJ; 2022 Jun; 377():o1568. PubMed ID: 35750332
    [No Abstract]   [Full Text] [Related]  

  • 5. A Public Health Crisis: Electronic Cigarettes, Vape, and JUUL.
    Walley SC; Wilson KM; Winickoff JP; Groner J
    Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31122947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine arms race: JUUL and the high-nicotine product market.
    Jackler RK; Ramamurthi D
    Tob Control; 2019 Nov; 28(6):623-628. PubMed ID: 30733312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US FDA approves menthol e-cigarette products.
    Furlow B
    Lancet Respir Med; 2024 Sep; 12(9):667. PubMed ID: 39098324
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market.
    Huang J; Duan Z; Kwok J; Binns S; Vera LE; Kim Y; Szczypka G; Emery SL
    Tob Control; 2019 Mar; 28(2):146-151. PubMed ID: 29853561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence and Use Characteristics of Adult JUUL Electronic Cigarette Users.
    Yingst J; Foulds J; Hobkirk AL
    Subst Use Misuse; 2021; 56(1):61-66. PubMed ID: 33118854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of U.S. Corporate Filings Provides a Proactive Approach to Inform Tobacco Regulatory Research Strategy.
    Sarles SE; Hensel EC; Robinson RJ
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33809725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in Constituents of E-Cigarette Products Containing Nicotine Analogues.
    Erythropel HC; Jabba SV; Silinski P; Anastas PT; Krishnan-Sarin S; Zimmerman JB; Jordt SE
    JAMA; 2024 Sep; 332(9):753-755. PubMed ID: 39110443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tobacco and vaping on the skin.
    Mitri A; Lin G; Waldman RA; Grant-Kels JM
    Clin Dermatol; 2021; 39(5):762-771. PubMed ID: 34785004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cigarette maker Juul will pay $462m to settle deceptive marketing allegations in six US states.
    Dyer O
    BMJ; 2023 Apr; 381():859. PubMed ID: 37068809
    [No Abstract]   [Full Text] [Related]  

  • 14. Youth access to JUUL online: eBay sales of JUUL prior to and following FDA action.
    Laestadius L; Wang Y
    Tob Control; 2019 Nov; 28(6):617-622. PubMed ID: 30185531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaping
    Rehan HS; Maini J; Hungin APS
    Curr Drug Saf; 2018; 13(2):92-101. PubMed ID: 29485005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Including E-Cigarettes in the FDA Rule Limiting Nicotine.
    Aaron DG; Wallace CR; Sinha MS
    JAMA; 2023 Sep; 330(12):1129-1130. PubMed ID: 37639253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rise of disposable JUUL-type e-cigarette devices.
    Williams R
    Tob Control; 2020 Dec; 29(e1):e134-e135. PubMed ID: 31806858
    [No Abstract]   [Full Text] [Related]  

  • 18. Smoking cessation among US adults: use of e-cigarettes, including JUUL, and NRT use.
    Patel M; Cuccia AF; Zhou Y; Kierstead EC; Briggs J; Schillo BA
    Tob Control; 2021 Nov; 30(6):693-695. PubMed ID: 32958602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defeating JUUL's Effort to Rewrite San Francisco's E-Cigarette Regulations.
    Sircar NR; Glantz SA
    Am J Public Health; 2021 Mar; 111(3):457-464. PubMed ID: 33476232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cigarette flavour enhancers: Flavoured pod attachments compatible with JUUL and other pod-based devices.
    Cwalina SN; Leventhal AM; Barrington-Trimis JL
    Tob Control; 2020 Dec; 29(e1):e127-e128. PubMed ID: 32273434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.